| IELSG46 | Integrated molecular and clinical profiling to optimize outcome prediction in Splenic Marginal Zone Lymphoma |
| Participants required: | Biological samples of at least 300 subjects |
| Investigator responsible(s): | D. Rossi |
| Objective(s): | To develop and validate an integrated clinic-molecular model for an accurate survival prognostication of newly diagnosed SMZL. |
